SCHEMBL874722

SCHEMBL874722

N=S(=O)(Nc1ccccc1)Nc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 3/20 0.58
CA2 P00918 3/20 0.58
CA1 P00915 2/20 0.58
IL1RN P18510 1/20 0.56
ERAP1 Q9NZ08 1/20 0.56
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
PKM P14618 2/20 0.52
ALDH1A1 P00352 2/20 0.52
CA12 O43570 3/20 0.47
CA9 Q16790 3/20 0.47
TMPRSS6 Q8IU80 2/20 0.44
PGR P06401 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
UQCRB P14927 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31219811 0.80 KEAP1 (0.67) KEAP1CA2CA1IL1RNERAP1
SCHEMBL593259 0.79 KEAP1 (0.58) KEAP1CA2CA1IL1RNERAP1
SCHEMBL59151 0.78 KEAP1 (0.64) KEAP1CA2CA1IL1RNERAP1
SCHEMBL6005110 0.78 CA2 (0.64) KEAP1CA2CA1IL1RNERAP1
SCHEMBL23141160 0.76 KEAP1 (0.61) KEAP1CA2CA1IL1RNERAP1
SCHEMBL2103296 0.74 KEAP1 (0.58) KEAP1CA2CA1IL1RNERAP1
SCHEMBL56693 0.74 KEAP1 (1.00) KEAP1CA2CA1IL1RNERAP1
SCHEMBL22250390 0.74 CA2 (0.58) KEAP1CA2CA1IL1RNERAP1
SCHEMBL5378696 0.74 CA2 (0.58) KEAP1CA2CA1IL1RNERAP1
SCHEMBL146561 0.74 CA2 (0.58) KEAP1CA2CA1IL1RNERAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2619186-A1 PROCESS FOR PREPARING PAN-CDK INHIBITORS OF THE FORMULA (I), AND INTERMEDIATES IN THE PREPARATION Bayer Pharma Aktiengesellschaft (DE) 2013-07-31 EP disclosed
WO-2012038411-A1 PROCESS FOR PREPARING PAN-CDK INHIBITORS OF THE FORMULA (I), AND INTERMEDIATES IN THE PREPARATION BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-29 WO disclosed